Huntsville, Alabama: A Big Win for Jobs and Medicine

Eli Lilly Invests $6 Billion in High-Tech Facility

Huntsville, Alabama, is set to become a major player in the pharmaceutical industry. Eli Lilly, a global leader in pharmaceuticals, is investing $6 billion in a new, state-of-the-art facility focused on small molecule synthetic and peptide medicines.

A Boost for the Local Economy

• 450 new jobs (engineers, lab technicians, and more)
• 3,000 construction jobs starting in 2026
• Facility expected to be operational by 2032
• For every $1 invested, up to $4 expected to flow into the local economy
• Ripple effect: More jobs in logistics, retail, and related sectors

Why Huntsville?

• Chosen from 300 applicants
• Close to the HudsonAlpha Institute for Biotechnology (a leading research and workforce training hub)
• Excellent utilities, transportation, and zoning benefits

Cutting-Edge Technology & Future Growth

• Utilizes AI and machine learning for quality and efficiency
• Part of Lilly’s plan to expand U.S. pharmaceutical manufacturing
• Strengthens domestic supply chains and medicine accessibility

A Historic Moment for Alabama

• Largest initial investment in Alabama’s history
• Governor Kay Ivey highlights Alabama’s biosciences legacy
• Huntsville Mayor Tommy Battle celebrates the city’s innovation heritage

Lilly’s Broader Expansion Plans

• Expanding facilities in Texas, Virginia, and Puerto Rico
• Another U.S. location in the works
• A game-changer for the pharmaceutical industry